Argenx Se ARGX
NASDAQ ARGX
$1,038.85 -14.61 (-1.39%)
As of: Sep 4, 2026 · 10:51 AM EDT

Argenx Se (ARGX) Other Non Operating Income (2016 - 2026)

Argenx Se's (ARGX) quarterly Other Non Operating Income came in at -$8.0 million in Q2 2026, down 116.47% YoY from $48.6 million in Q2 2025, and up 27.27% on a QoQ basis from -$11.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Other Non Operating Income (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has 11 years of Other Non Operating Income data on file, last reported at -$8.0 million in Q2 2026.

  • Quarterly Other Non Operating Income fell 116.47% year-over-year to -$8.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$29.2 million (down 153.53% YoY) and the FY2025 annual result came in at $65.8 million, up 236.47% from the prior year.
  • Other Non Operating Income climbed to -$8.0 million in Q2 2026, from -$11.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $60.3 million in Q4 2022 to a low of -$54.9 million in Q4 2024.
  • A 5-year average of -$1.1 million and a median of -$7.6 million in 2022 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 542.15% — and 2025, when it jumped 714.51%.
  • Tracing ARGX's Other Non Operating Income over 5 years: stood at $60.3 million in 2022, then tumbled by 37.9% to $37.4 million in 2023, then tumbled by 246.78% to -$54.9 million in 2024, then jumped by 84.77% to -$8.4 million in 2025, then advanced by 4.34% to -$8.0 million in 2026.
  • The last three Other Non Operating Income figures came in at -$8.0 million (Q2 2026), -$11.0 million (Q1 2026), and -$8.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.68 Bn 131.82 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.68 Bn 77.68 Bn 3.93 Bn
3 Argenx Se 63.67 Bn 58.48 Bn 1.37 Bn
4 Moderna 57.02 Bn 51.88 Bn 52.00 Mn
5 Revolution Medicines 43.83 Bn 43.83 Bn -
6 BeOne Medicines 39.97 Bn 34.87 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.23 Bn 31.93 Bn 992.69 Mn
8 Royalty Pharma 28.56 Bn 27.72 Bn -
9 Insmed 27.54 Bn 26.38 Bn 358.27 Mn
10 Incyte 25.49 Bn 20.95 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -8.36 Mn
Sep 30, 2025 -1.85 Mn
Jun 30, 2025 48.57 Mn
Mar 31, 2025 27.00 Mn
Dec 31, 2024 -54.92 Mn
Sep 30, 2024 33.93 Mn
Jun 30, 2024 -7.90 Mn
Mar 31, 2024 -19.31 Mn
Dec 31, 2023 37.42 Mn
Sep 30, 2023 -32.51 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 11.17 Mn
Dec 31, 2022 60.26 Mn
Sep 30, 2022 -39.61 Mn
Jun 30, 2022 -46.17 Mn
Mar 31, 2022 -7.21 Mn
Dec 31, 2021 -14.06 Mn
Sep 30, 2021 -17.62 Mn